Cargando…

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis

BACKGROUND: There is evidence that antipsychotic drugs differ in their effect on the cognitive symptoms of schizophrenia. So far, there is no comprehensive systematic review available that would enable providers and patients to make informed choices regarding this important aspect of treatment. With...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feber, Lena, Peter, Natalie, Schneider-Thoma, Johannes, Siafis, Spyridon, Bighelli, Irene, Hansen, Wulf-Peter, Prates Baldez, Daniel, Salanti, Georgia, Keefe, Richard S. E., Engel, Rolf R., Leucht, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037873/ https://www.ncbi.nlm.nih.gov/pubmed/36959619 http://dx.doi.org/10.1186/s13643-023-02213-5

Ejemplares similares

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Siafis, Spyridon, et al.
Publicado: (2023)

T200. METABOLIC SIDE EFFECTS OF ANTIPSYCHOTIC DRUGS – PROTOCOL OF A SYSTEMATIC REVIEW AND NETWORK- METAANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
por: Schneider-Thoma, Johannes, et al.
Publicado: (2021)

M201. MODERATORS OF WEIGHT GAIN IN RANDOMIZED CONTROLLED TRIALS OF SCHIZOPHRENIA – A META-REGRESSION ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis
por: Chiocchia, Virginia, et al.
Publicado: (2023)

Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence
por: Bighelli, Irene, et al.
Publicado: (2020)

Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2023)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2019)

Informing the development of a decision aid: Expectations and wishes from service users and psychiatrists towards a decision aid for antipsychotics in the inpatient setting
por: Müller, Katharina, et al.
Publicado: (2023)

How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis
por: Gutsmiedl, Katharina, et al.
Publicado: (2020)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

T6. SECOND GENERATION ANTIPSYCHOTIC DRUGS AND MORTALITY: A META-ANALYSIS OF PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIALS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020)

The Added Value of Liquid Antipsychotics: The Case of Quetiapine
por: Papazisis, Georgios, et al.
Publicado: (2019)

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials
por: Bighelli, Irene, et al.
Publicado: (2018)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022)

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
por: Siafis, Spyridon, et al.
Publicado: (2020)

Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia
por: Siafis, Spyridon, et al.
Publicado: (2022)

Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
por: Siafis, Spyridon, et al.
Publicado: (2018)

F214. PSYCHOLOGICAL INTERVENTIONS FOR POSITIVE SYMPTOMS IN SCHIZOPHRENIA: A NETWORK META-ANALYSIS
por: Bighelli, Irene, et al.
Publicado: (2018)

Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2022)

Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta‐analysis
por: Mavridis, Dimitris, et al.
Publicado: (2015)

Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis
por: Bighelli, Irene, et al.
Publicado: (2018)

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
por: Tajika, Aran, et al.
Publicado: (2023)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health
por: Leucht, Stefan, et al.
Publicado: (2021)

An efficient way to assess the effect of COVID-19 on mental health in the general population
por: Salanti, Georgia, et al.
Publicado: (2021)

Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review
por: Wagner, Elias, et al.
Publicado: (2021)

Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder
por: Siafis, Spyridon, et al.
Publicado: (2021)

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
por: Barbui, Corrado, et al.
Publicado: (2016)

Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study
por: Nikolakopoulou, Adriani, et al.
Publicado: (2018)

Sex differences in symptomatology in people with schizophrenia and other psychotic disorders: protocol for a systematic review and pairwise meta-analysis of observational studies
por: Ferrer-Quintero, Marta, et al.
Publicado: (2022)

Α Markov model for longitudinal studies with incomplete dichotomous outcomes
por: Efthimiou, Orestis, et al.
Publicado: (2016)

Magnetic scattering: pairwise little group and pairwise helicity
por: Csaki, Csaba
Publicado: (2021)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Bighelli, Irene, et al.
Publicado: (2022)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i15f1gjvj4s7c9i4hnv56nnuhe